Project Grant R01HL175556
Award Date
6/10/25
Completion Date
4/30/29
Dollars Obligated
$802K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
미국 뉴욕
Similar Awards
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $128,100.00 to the New York Blood Center, Inc. to evaluate methods for improving homing and engraftment efficiency of CD34+ cells from sickle cell disease (SCD) patients. The research aims to determine if co-infusing the CD34+ cells with the CD34-negative fraction, which normally gets discarded, can assist with HSC homing and...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $1,123,357 to Childrens Hospital Medical Center in Cincinnati, Ohio. The research project aims to define the physiology of blood cell production in the bone marrow tissue during homeostasis, inflammation, and regeneration. Key objectives include: Dissecting the function of specialized microenvironments that serve as niches for...
This $493,810 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to understand the cellular interactions and programming of hematopoietic stem and progenitor cells (HSPCs) within the perivascular niche. The research, conducted by the University of Wisconsin - Madison, aims to decipher the mechanisms governing HSPC fate decisions and their long-term impact on hematopoiesis. Specifically,...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $380,383 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The Johns Hopkins University. The grant, awarded on April 21, 2025, supports research to understand and prevent DNA damage in hematopoietic (blood) stem cells, which is critical for maintaining their regenerative capacity. The project aims to dissect the role of aldehyde-metabolizing enzymes in protecting stem cells, uncover novel disease...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $566,022 to Albert Einstein College of Medicine to investigate the role of the sympathetic nervous system in regulating hematopoietic stem cell aging. The research aims to define the mechanisms by which neural signals, mediated through reactive oxygen species and connexin gap junctions, impact the function of mesenchymal stromal...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the Cardiovascular Diseases Research federal grant program (CFDA 93.837), provides $680,321 to support research on how the protein DLK1 regulates hematopoietic stem cell (HSC) quiescence through inhibition of receptor signaling. The key objectives are to: 1) determine if DLK1 maintains and/or expands quiescent HSCs, 2) elucidate how DLK1 interactions with receptor components within membrane condensates...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), aims to elucidate the key endothelial mechanisms that facilitate the extravasation of hematopoietic stem cells (HSCs) into their bone marrow niches. The $734,607 award, with a project period from May 1, 2025 to February 28, 2030, will support studies using the zebrafish model and a human blood vessel model to define the endothelial receptor...
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded a $457,500 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to the University of Massachusetts Boston. The 3-year grant, commencing on January 15, 2025, supports research to elucidate the molecular mechanisms by which the non-canonical Wnt5 signaling pathway regulates hematopoiesis, the process of blood cell formation. The proposed work leverages the...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $130,337 to The Trustees of Columbia University in the City of New York to conduct research on understanding the nature and regulation of extramedullary hematopoiesis (EMH) in the liver. The project aims to characterize the cellular components of the hematopoietic stem cell (HSC) niche in the EMH liver, identify HSC clones...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $146,876 to the Coriell Institute for Medical Research to expand human umbilical cord blood hematopoietic stem cells (HSCs) using PPAR-α agonists. The goal is to develop new methods to expand functional HSCs from cryopreserved umbilical cord blood samples in the NHLBI Biologic Biospecimen Repository. This would enable enhanced...